Skip to main content

Table 6 Currently developed delivery platforms in RNA therapeutics

From: Research progress on non-protein-targeted drugs for cancer therapy

Delivery platform

Classification

Pros

Cons

Viral vectors

Adenovirus, adeno-associated virus, lentivirus

High transfection efficiency

Immunogenicity, high cost, toxicity

Lipid-based delivery system

Micelles, liposomes, lipid nanoparticles

Easy to production, lack of immunogenicity, biodegradability

Difficult to large-scale

Polymer-based nanoparticles

Cationic polymers, dendrimers

Small size, low immunogenicity and toxicity

Poor biodegradability

Inorganic nanoparticles

Gold nanoparticles, silica nanoparticles, carbon nanotubes

Easy functionalization, good biocompatibility, high load capacity, mass production

Limited transfection efficiency, lack of clinical trials